New Snack

Stack Pie

New limited-time offer from Pie Face Pie Shop in Japan. On top of the warm savoury pie are sour cream onion potato, avocado paste and demi glaze.

The price of each pie is 594 yen.

Video: Breakfasts Around the World

Watch video at The Washington Post (3:49 minutes) . . . . .

Read more:

All the proof you need that Americans basically eat dessert for breakfast . . . . .

Important Advance Made with New Approach to Control Cancer, Not Eliminate It

Researchers have created a new drug delivery system that could improve the effectiveness of an emerging concept in cancer treatment – to dramatically slow and control tumors on a long-term, sustained basis, not necessarily aiming for their complete elimination.

The approach, called a “metronomic dosage regimen,” uses significantly lower doses of chemotherapeutic drugs but at more frequent time intervals. This would have multiple goals of killing cancer cells, creating a hostile biological environment for their growth, reducing toxicity from the drug regimen and avoiding the development of resistance to the cancer drugs being used.

A system just published in Chemistry of Materials by a group of researchers from Oregon and the United Kingdom offers an even more effective way to deliver such drugs and may be able to greatly improve this approach, scientists say. Further testing is needed in both animals and humans for safety and efficacy.

“This new system takes some existing cancer therapy drugs for ovarian cancer, delivers both of them at the same time and allows them to work synergistically,” said Adam Alani, an associate professor in the Oregon State University/Oregon Health & Science University College of Pharmacy, and lead author on the new study.

“Imagine if we could manage cancer on a long-term basis as a chronic condition, like we now do high blood pressure or diabetes. This could be a huge leap forward.”

This approach is still in trial stages, Alani said, but shows promise. In some prior work with related systems in animal tests, OSU and collaborating researchers have been able to completely eradicate tumors.

Total remission, Alani said, may be possible with metronomic dosage, but the initial goal is not only to kill cancer cells but to create an environment in which it’s very difficult for them to grow, largely by cutting off the large blood supply these types of cells often need.

Most conventional cancer chemotherapy is based on the use of “maximum tolerable doses” of a drug, in an attempt to completely eliminate cancer or tumors. In some cases such as ovarian cancer, however, drug-free intervals are needed to allow patient recovery from side effects, during which tumors can sometimes begin to grow again or develop resistance to the drugs being used.

The types of cancers this approach may best lend itself to are those that are quite complex and difficult to treat with conventional regimens based on “maximum tolerable dose.” This includes ovarian, sarcoma, breast, prostate, and lung cancers.

One example of the new metronomic regimen, in this instance, is use of two drugs already common in ovarian cancer treatment – paclitaxel and rapamycin – but at levels a tenth to a third of the maximum tolerable dose. One drug attacks cancer cells; the other inhibits cancer cell formation and the growth of blood vessels at tumor sites.

The new system developed in this research takes the process a step further. It attaches these drugs to polymer nanoparticles that migrate specifically into cancer cells and are designed to release the drugs at a particular level of acidity that is common to those cells. The low doses, careful targeting of the drugs and their ability to work in synergy at the same time appeared to greatly increase their effectiveness, while almost completely eliminating toxicity.

“Our goal is to significantly reduce tumors, slow or stop their regrowth, and allow a person’s body and immune system time to recover its health and natural abilities to fight cancer,” Alani said. “I’m very optimistic this is possible, and that it could provide an entirely new approach to cancer treatment.”

Source: Oregon State University

Bite-size Toasts with Caramelized Shallots and Cheese


3 oz Parmesan cheese, in one piece
2 tablespoons butter, at room temperature
1 small or medium baguette

Caramelized shallots

1 tablespoon butter, at room temperature
1 cup thinly sliced shallots, about 8 oz
1/2 tablespoon sugar
3 tablespoons sherry
2 sprigs of thyme, plus extra to serve
sea salt and freshly ground black pepper


  1. To cook the shallots, melt the butter in a nonstick skillet over gentle heat. Add the shallots, sprinkle with a little salt, and cook, stirring, for 5-10 minutes until translucent and golden.
  2. Sprinkle with the sugar and continue cooking for about 5 minutes until the sugar begins to caramelize.
  3. Pour over the sherry, add the thyme, and cook gently for about 10 minutes until the shallots are tender.
  4. Increase the heat and bubble vigorously until all the liquid has evaporated. Add salt and pepper to taste. Remove from the heat and cover to keep warm.
  5. Grate half the Parmesan and pare the rest into shavings using a vegetable peeler.
  6. Put the butter in a bowl, add the grated Parmesan and mix well.
  7. Slice the baguette. Put some of the Parmesan butter on each one, then top with the Parmesan shavings. Toast under a preheated broiler for about 3 minutes until golden and bubbling. Spoon the caramelized shallots on top, add extra thyme, if using, and serve.

Makes 8 to 12 bite-size toasts.

Source: On Toast

In Pictures: Bagels Served at Restaurants in New York City

Today’s Comic